Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.
作者信息
Václavík Jan, Szotkowski Tomás, Hutyra Martin, Kozák Jirí, Lukl Jan, Táborský Milos
出版信息
Am J Hematol. 2010 Apr;85(4):296-9. doi: 10.1002/ajh.21635.
PMID:20169542
Abstract
摘要
相似文献
1
Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.
Am J Hematol. 2010 Apr;85(4):296-9. doi: 10.1002/ajh.21635.
2
3
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.
Haematologica. 2007 Sep;92(9):1173-9. doi: 10.3324/haematol.11420. Epub 2007 Aug 1.
4
[The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib].
Zhonghua Yi Xue Za Zhi. 2005 Feb 23;85(7):448-52.
5
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
Haematologica. 2004 Feb;89(2):236-7.
6
Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
Am J Hematol. 2014 Jan;89(1):115. doi: 10.1002/ajh.23588. Epub 2013 Oct 15.
7
Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.
Oncotarget. 2014 Nov 15;5(21):10407-20. doi: 10.18632/oncotarget.2090.
8
Imatinib-responsive hypereosinophilic syndrome.
Leuk Res. 2006 Aug;30(8):915-6. doi: 10.1016/j.leukres.2006.02.007. Epub 2006 Mar 13.
9
Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.
Med Oncol. 2012 Jun;29(2):1073-6. doi: 10.1007/s12032-011-9831-1. Epub 2011 Jan 22.
10
[Identification of clonal proliferation of T cell and FIP1L1-PDGFRalpha fusion gene in hypereosinophilic syndrome associated with lymphomatoid papulosis which showed rapid and complete response to the treatment with imatinib].
Nihon Naika Gakkai Zasshi. 2007 Dec 10;96(12):2794-7. doi: 10.2169/naika.96.2794.
Zotero 插件